Innovative Nanozymes Cross the Blood-Brain Barrier to Combat Parkinson’s Disease
Researchers have developed chiral nanozyme-based therapies that effectively traverse the blood-brain barrier, mitigate neuroinflammation, and improve Parkinson’s symptoms in preclinical models. Key Highlights: 1. Research QuestionCan chiral nanozymes integrated into…